跳至主要内容
临床试验/JPRN-UMIN000020358
JPRN-UMIN000020358已完成未知

Preliminary study on recombinant human soluble thrombomodulin (rTM) administration for treatment of pneumonia-induced acute respiratory distress syndrome (ARDS) complicated with disseminated intravascular coagulation(DIC) and sepsis, including avian influenza virus infection - Recombinant human soluble thrombomodulin (rTM) for treatment of pneumonia-induced ARDS complicated with DIC and sepsis, including avian influenza virus infection

ational Hospital for Pediatrics, Nanoi, Vietnam0 个研究点目标入组 3 人开始时间: 2015年12月28日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
3

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1months-old 至 180months-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who fulfill any of the followings are excluded 1. Patients with severe renal dysfunction (creatinine clearance < 10mL/min) 2. Patients with bleeding symptoms. 3. Patients whom the treating doctor deems, for any reason, to be ineligible.

研究者

发起方
ational Hospital for Pediatrics, Nanoi, Vietnam

相似试验